PTGS2 and cancer: Notably, cancer cells which lacked or expressed basal levels of COX-2 but could not upregulate its transcription post-chemotherapy behaved similar to untreated cells, uncovering the increase in COX-2 as a major determinant of the inflammatory properties of chemotherapy-treated cancer cells.